| Cat.No. | Name | Information |
|---|---|---|
| M9360 | Dicoumarol | Dicoumarol (Dicoumarin) is an inhibitor of both NAD(P)H:quinone oxidoreductase 1 (NQO1) and PDK1 with IC50s of 0.37 and 19.42 μM, respectively. |
| M7562 | BX517 | BX517 is a potent and selective inhibitor of PDK1 with IC50 of 6 nM. |
| M4832 | NVP-BAG956 | NVP-BAG956 is a potent, ATP-competitive and selective dual PDK1 and class I PI 3-K inhibitor (IC50 values are 245, 56, 446, 35 and 117 nM for PDK1 and PI 3-K p110 -α, -β, -δ, and -γ respectively). |
| M2423 | AZD7545 | AZD7545 is a potent PDHK inhibitor with IC50 of 36.8 nM and 6.4 nM for PDHK1 and PDHK2, respectively. |
| M2311 | BX-912 | BX912 is a selective potent PDK1 inhibitor with IC50 of 12 nM. |
| M2310 | BX-795 | BX795 is a potent and specific TBK1, IKKε and PDK-1 inhibitor with IC50 of 6 nM, 41 nM and 111 nM, respectively. |
| M2115 | GSK2334470 | GSK2334470 is a highly specific and potent inhibitor of PDK1 with IC50 of 10 nM. |
| M1848 | OSU-03012 | OSU-03012 is a novel and potent, blood-brain permeable inhibitor of PDK-1 with an IC50 of 5 µM. |
| M55320 | MP7 | MP7 (PDK1 inhibitor) is a phosphoinositide-dependent kinase-1 (PDK1) inhibitor. |
| M43386 | PDKtide | PDKtide is a biological active peptide. |
| M28769 | PDK1-IN-RS2 | PDK1-IN-RS2 is a mimic of peptide docking motif (PIFtide) and is a substrate-selective PDK1 inhibitor with a Kd of 9 μM. PDK1-IN-RS2 suppresses the activation of the downstream kinases S6K1 by PDK1. |
| M27891 | PS47 | PS47 is an inactive E-isomer of PS48. PS48 is an activator of PDK1. PS47 can be used as a negative control for PS48. |
| M20816 | PS210 | PS210 is a potent activator of PDK1 that binds to the PIF-pocket and allosterically modulates the active site of PDK1. |
| M20385 | WAY-299338 | WAY-299338 is a modulator of the Protein Kinase PDK1. |
| M20367 | WAY-298630 | WAY-298630 is a PDK1 modulator |
| M20162 | WAY-352098 | WAY-352098 is a modulator of the Protein Kinase PDK1 |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
